Back to Search
Start Over
Better than RECIST and faster than iRECIST: Defining the immunotherapy progression decision score to better manage progressive tumors on immunotherapy
- Source :
- Annals of Oncology, Annals of Oncology, 2022, 33, pp.S595-S596. ⟨10.1016/j.annonc.2022.07.159⟩
- Publication Year :
- 2022
- Publisher :
- HAL CCSD, 2022.
-
Abstract
- International audience
- Subjects :
- [SDV]Life Sciences [q-bio]
Subjects
Details
- Language :
- English
- ISSN :
- 09237534 and 15698041
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology, Annals of Oncology, 2022, 33, pp.S595-S596. ⟨10.1016/j.annonc.2022.07.159⟩
- Accession number :
- edsair.od.......165..d1ec9cc0547bd1a77b731b3075d9c45d
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.159⟩